Diacylglycerol lipase alpha promotes hepatocellular carcinoma progression and induces lenvatinib resistance by enhancing YAP activity
Abstract As an important hydrolytic enzyme that yields 2-AG and free fatty acids, diacylglycerol lipase alpha (DAGLA) is involved in exacerbating malignant phenotypes and cancer progression, but the role of the DAGLA/2-AG axis in HCC progression remains unclear. Here, we found that the upregulation...
Main Authors: | Yu-Chuan Yan, Guang-Xiao Meng, Chun-Cheng Yang, Ya-Fei Yang, Si-Yu Tan, Lun-Jie Yan, Zi-Niu Ding, Yun-Long Ma, Zhao-Ru Dong, Tao Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Publishing Group
2023-07-01
|
Series: | Cell Death and Disease |
Online Access: | https://doi.org/10.1038/s41419-023-05919-5 |
Similar Items
-
Localization of diacylglycerol lipase alpha and monoacylglycerol lipase during postnatal development of the rat retina
by: Bruno eCécyre, et al.
Published: (2014-12-01) -
Regulation of adult neurogenesis by the endocannabinoid-producing enzyme diacylglycerol lipase alpha (DAGLa)
by: Lena-Louise Schuele, et al.
Published: (2022-01-01) -
Engineering the Thermostability of the Mono- and Diacylglycerol Lipase SMG1 for the Synthesis of Diacylglycerols
by: Lilang Li, et al.
Published: (2022-12-01) -
Prognostic model for predicting outcome and guiding treatment decision for unresectable hepatocellular carcinoma treated with lenvatinib monotherapy or lenvatinib plus immunotherapy
by: De-Zhen Guo, et al.
Published: (2023-02-01) -
Identification and quantification of diacylglycerols in HDL and accessibility to lipase
by: C Vieu, et al.
Published: (1996-05-01)